Product Information
METRONIDAZOLE 0.75% CREAM is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.2571 per GM under NDC 72578012908. Its NADAC has been published 152 times since Nov 8, 2023.
FDA first approved this application on Apr 21, 2023. Its Orange Book therapeutic-equivalence code is BX.
Strength
7.5 mg/g
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578012908
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA217128FDA Approved
4/21/2023
TE Code
BX
On Market Since
5/31/2023
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 0.75% CREAM has been published 152 times since Nov 8, 2023, and over the history we have for it it has declined 51.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2571 per GM |
|---|---|
| All-time high | $0.6214 (Dec 13, 2023) |
| All-time low | $0.2184 (Nov 20, 2024) |
| 52-week high | $0.3207 |
| 52-week low | $0.2571 |
| Median price | $0.3009 |
| Average price | $0.3325 |
| Largest weekly change | -35.0% (Feb 21, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metronidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 0.75% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 0.75% CREAM, manufactured by Viona Pharmaceuticals Inc., is $0.2571 per GM (NDC 72578012908), effective Sep 30, 2026.
How has the price of METRONIDAZOLE 0.75% CREAM changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 0.75% CREAM has declined 51.6%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 0.75% CREAM?
Since Nov 8, 2023, the NADAC for METRONIDAZOLE 0.75% CREAM has ranged from a low of $0.2184 (Nov 20, 2024) to a high of $0.6214 (Dec 13, 2023), with a median of $0.3009 per GM.
Are there cheaper alternatives to METRONIDAZOLE 0.75% CREAM?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE 0.75% CREAM in a comparable dosage form, but none are currently priced below it.
Who manufactures METRONIDAZOLE 0.75% CREAM?
METRONIDAZOLE 0.75% CREAM (NDC 72578012908) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.